Assessing Whether Novavax, Inc (NASDAQ: NVAX) Is Over- Or Undervalued

Novavax, Inc (NVAX) concluded trading on Thursday at a closing price of $7.0, with 4.76 million shares of worth about $33.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -17.70% during that period and on July 17, 2025 the price saw a gain […]

Novavax, Inc (NASDAQ: NVAX) Is Getting Increasingly Hard To Ignore

Currently, there are 161.96M common shares owned by the public and among those 147.54M shares have been available to trade. The company’s stock has a 5-day price change of 11.75% and 12.82% over the past three months. NVAX shares are trading -43.90% year to date (YTD), with the 12-month market performance down to -12.44% lower. […]

Novavax, Inc (NASDAQ: NVAX) – Not A Clear Buying Opportunity?

Novavax, Inc (NVAX) concluded trading on Wednesday at a closing price of $6.76, with 5.45 million shares of worth about $36.83 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -18.36% during that period and on July 02, 2025 the price saw a gain […]

Uncovering Institutional Buying In Novavax, Inc (NASDAQ: NVAX)

Currently, there are 161.96M common shares owned by the public and among those 147.54M shares have been available to trade. The company’s stock has a 5-day price change of -7.68% and -15.60% over the past three months. NVAX shares are trading -53.84% year to date (YTD), with the 12-month market performance down to -19.28% lower. […]

Novavax, Inc (NASDAQ: NVAX): Hunting Genuine Value In Market Debris

Currently, there are 161.96M common shares owned by the public and among those 147.60M shares have been available to trade. The company’s stock has a 5-day price change of -9.86% and -18.36% over the past three months. NVAX shares are trading -19.28% year to date (YTD), with the 12-month market performance down to -56.88% lower. […]

Novavax, Inc (NASDAQ: NVAX) Hogging The Spotlight Today

Currently, there are 161.96M common shares owned by the public and among those 147.60M shares have been available to trade. The company’s stock has a 5-day price change of -0.83% and -9.09% over the past three months. NVAX shares are trading -10.45% year to date (YTD), with the 12-month market performance down to -63.18% lower. […]

Novavax, Inc (NVAX): Street Finally Waking Up

Currently, there are 161.96M common shares owned by the public and among those 147.60M shares have been available to trade. The company’s stock has a 5-day price change of -1.63% and -5.47% over the past three months. NVAX shares are trading -9.70% year to date (YTD), with the 12-month market performance down to -52.39% lower. […]

Investors Should Take Note Of Novavax, Inc (NVAX)

Novavax, Inc (NVAX) concluded trading on Wednesday at a closing price of $6.92, with 7.88 million shares of worth about $54.5 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -13.93% during that period and on Wednesday the price saw a loss of about […]

Novavax, Inc (NVAX) Volatility Spurs A Quest For Clarity

Currently, there are 161.96M common shares owned by the public and among those 147.60M shares have been available to trade. The company’s stock has a 5-day price change of 22.08% and -6.18% over the past three months. NVAX shares are trading -3.73% year to date (YTD), with the 12-month market performance down to -40.00% lower. […]

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.